EUVIMEDEUVIMED entdecken
Klinische Studie

CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity

Martin K Madsen, Anja Sofie Petersen iD, Dea S Stenbaek, Inger Marie Sørensen, Harald Schiønning, Tobias Fjeld, Charlotte H Nykjaer, Sara Marie Ulv Larsen, Maria Grzywacz, Tobias Mathiesen, Ida L Klausen, Oliver Overgaard-Hansen und 6 weitere

Headache: The Journal of Head and Face Pain · 2024

DOI: 10.1111/head.14656 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Headache: The Journal of Head and Face Pain, 2024. Verfasst von Martin K Madsen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cluster Headache, Psilocybin. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Augustinusfonden, Innovation Fund Denmark, Lundbeck Foundation through Danish Neurological Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the feasibility and prophylactic effect of psilocybin as well as its effects on hypothalamic functional connectivity (FC) in patients with chronic cluster headache (CCH).

Background

CCH is an excruciating and difficult‐to‐treat disorder with incompletely understood pathophysiology, although hypothalamic dysfunction has been implicated. Psilocybin may have beneficial prophylactic effects, but clinical evidence is limited.

Methods

In this small open‐label clinical trial, 10 patients with CCH were included and maintained headache diaries for 10 weeks. Patients received three doses of peroral psilocybin (0.14 mg/kg) on the first day of weeks five, six, and seven. The first 4 weeks served as baseline and the last 4 weeks as follow‐up. Hypothalamic FC was determined using functional magnetic resonance imaging the day before the first psilocybin dose and 1 week after the last dose.

Results

The treatment was well tolerated. Attack frequency was reduced by mean (standard deviation) 31% (31) from baseline to follow‐up ( p FWER = 0.008). One patient experienced 21 weeks of complete remission. Changes in hypothalamic–diencephalic FC correlated negatively with a percent change in attack frequency ( p FWER = 0.03, R = −0.81), implicating this neural pathway in treatment response.

Conclusion

Our results indicate that psilocybin may have prophylactic potential and implicates the hypothalamus in possible treatment response. Further clinical studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cluster HeadachePsilocybinHumansHypothalamusMagnetic Resonance ImagingNeural Pathways

Stichwörter der Autor:innen

cluster headachefunctional connectivityfunctional magnetic resonance imaginghypothalamuspsilocinpsilocybin

Substanzen

Psilocybin

Autor:innen und Institutionen

  • Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Danish Headache Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Forensic Medicine, Section of Forensic Chemistry, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Anja Sofie Petersen, Rigmor H Jensen, Gitte M Knudsen

Förderung

  • Augustinusfonden
  • Innovation Fund Denmark
  • Lundbeck Foundation through Danish Neurological Society
  • Rigshospitalet's Research Council
  • Innovationsfonden

Zitieren

APA

Madsen, M. K., Petersen, A. S., Stenbaek, D. S., Sørensen, I. M., Schiønning, H., Fjeld, T., Nykjaer, C. H., Larsen, S. M. U., Grzywacz, M., Mathiesen, T., Klausen, I. L., Overgaard-Hansen, O., Brendstrup-Brix, K., Linnet, K., Johansen, S. S., Fisher, P. M., Jensen, R. H., & Knudsen, G. M. (2024). CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14656

Vancouver

Madsen MK, Petersen AS, Stenbaek DS, Sørensen IM, Schiønning H, Fjeld T, et al. CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity. Headache: The Journal of Head and Face Pain. 2024. doi:10.1111/head.14656

BibTeX
@article{Madsen2024,
  author = {Madsen, Martin K and Petersen, Anja Sofie and Stenbaek, Dea S and Sørensen, Inger Marie and Schiønning, Harald and Fjeld, Tobias and Nykjaer, Charlotte H and Larsen, Sara Marie Ulv and Grzywacz, Maria and Mathiesen, Tobias and Klausen, Ida L and Overgaard-Hansen, Oliver and Brendstrup-Brix, Kristoffer and Linnet, Kristian and Johansen, Sys S and Fisher, Patrick M and Jensen, Rigmor H and Knudsen, Gitte M},
  title = {CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  doi = {10.1111/head.14656}
}
Kostenlos starten →